|
Enabling Better Planned Transitions of Malaria Programming from Global Fund Financing to Domestic Financing |
Sara Fewer |
Eritrea, Ethiopia, Kenya, Malawi, Mozambique, Rwanda, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Benin, Burkina Faso, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Niger, Afghanistan, Bangladesh, India, Nepal, Brunei, Cambodia, Myanmar, Honduras, Cuba, Haiti |
|
|
|
AVENIR: Assessing the impact of azithromycin on child mortality in Niger |
Thomas Lietman, MD |
Niger |
|
|
|
Planning Grant for a large scale azithromycin trial for prevention of under-5 mortality in Niger |
Thomas Lietman, MD |
Niger |
|
|
|
Implementation of The Global Fund's Programmatic Quality Assurance and Improvement Approach |
George Rutherford, MD |
Burundi, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Lesotho, Benin, Burkina Faso, Gambia, Guinea, Guinea-Bissau, Liberia, Mali, Niger, Sierra Leone, Togo, Kyrgyzstan, North Korea, Afghanistan, India, Nepal, Laos, Syria, Honduras |
|
|
|
PREDICT-2 |
Dean Jamison, PhD |
Kenya, Rwanda, South Sudan, Uganda, Tanzania, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Niger, Nigeria, Senegal, Sierra Leone, Togo, Bangladesh, India, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand |
|
|
|
Office of the UN Special Envoy for Tuberculosis |
Eric Goosby, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Central Asia, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, Hong Kong S.A.R., China, North Korea, South Korea, Macao S.A.R., China, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Sri Lanka, Brunei, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian Territory, Qatar, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Jersey, Kosovo, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Caribbean, Anguilla, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Puerto Rico, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Bermuda, Canada, Greenland, U.S. Virgin Islands, American Samoa, Northern Mariana Islands, Australia, Cook Islands, Guam, French Polynesia, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, New Zealand, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu |
|
|
|
Systematic reviews to support the Antiretroviral Therapy (ART) Consolidated Guidelines - 2014/HTM/HIV/007 |
George Rutherford, MD |
Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Western Africa, Benin, Burkina Faso, Ivory Coast, Gambia, Ghana, Liberia, Mali, Mauritania, Niger, Nigeria, Sierra Leone, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, South Korea, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Georgia, Iraq, Israel, Jordan, Kuwait, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Bosnia and Herzegovina, Bulgaria, Croatia, Macedonia, Moldova, Slovenia, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Paraguay, Peru, Uruguay, Venezuela, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Dominica, Dominican Republic, Haiti, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, American Samoa, Northern Mariana Islands, Guam, Fiji, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Vanuatu |
|
|
|
The Contribution of Unsafe Blood Transfusion to HIV Transmission in Africa: A Literature Review |
Malika Morar, MS |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo |
|
|
|
Interventions for Improving Retention in Antiretroviral Therapy (ART) Programs (PO 200988865) |
George Rutherford, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Brunei, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Jordan, Lebanon, Syria, Turkey, Yemen, Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Montenegro, Slovakia, Slovenia, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Ecuador, Peru, Uruguay, Venezuela, Haiti, Jamaica |
|
|
|
Mortality Reduction After Oral Azithromycin |
Thomas Lietman, MD |
Ethiopia, Niger |
|
|
|
WHO Adolescent HTC Review Update (PO# 200660799) |
George Rutherford, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Western Africa, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, Hong Kong S.A.R., China, North Korea, Japan, Macao S.A.R., China, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Brunei, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian Territory, Qatar, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Jersey, Kosovo, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Anguilla, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Puerto Rico, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Bermuda, Canada, Greenland, U.S. Virgin Islands, American Samoa, Northern Mariana Islands, Australia, Cook Islands, Guam, French Polynesia, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, New Zealand, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu |
|
|
|
University of California Global Health Institute Program for Fellows and Scholars (UCGHI-PFS) |
Craig Cohen, MD, MPH |
Burundi, Kenya, Mozambique, Rwanda, Central African Republic, Benin, Burkina Faso, Gambia, Guinea, Guinea-Bissau, Niger, Sierra Leone, Kyrgyzstan, South Korea, Afghanistan, Bangladesh, Nepal, Cambodia, Myanmar, Haiti |
|
|
|
Epidemiology and clinical manifestations of chlamydial infections |
Julius Schachter, PhD |
Ethiopia, Niger, India, Nepal, Thailand, Mexico |
|
|
|
Global Health Sciences Clinical Scholars Program Immersion Experience |
Christopher Stewart, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, North Korea, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Israel, Jordan, Lebanon, Palestinian Territory, Syria, Turkey, Yemen, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Kosovo, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Romania, Russia, Serbia, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Antigua and Barbuda, Cuba, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Saint Lucia, Saint Vincent and the Grenadines, American Samoa, Fiji, Kiribati, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu |
|
|
|
University of California Global Health Institute Women's Health and Empowerment Center of Expertise Post-Doctoral Fellowship Program |
Craig Cohen, MD, MPH |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, North Korea, South Korea, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Jordan, Lebanon, Palestinian Territory, Syria, Turkey, Yemen, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Kosovo, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Romania, Russia, Serbia, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Antigua and Barbuda, Cuba, Dominica, Grenada, Haiti, Jamaica, Saint Lucia, Saint Vincent and the Grenadines, American Samoa, Fiji, Kiribati, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu |
|
|
|
Assessment of Affordable Medicines Facility for Malaria Treatment |
|
Kenya, Madagascar, Uganda, Tanzania, Ghana, Niger, Nigeria, Cambodia |
|
|
|
Leveraging Core Groups -- A New Way to Protect Against Infectious Trachoma |
Thomas Lietman, MD |
Ethiopia, Tanzania, Gambia, Niger, India |
|
|
|
Research to Programs for Trachoma Elimination |
Thomas Lietman, MD |
Tanzania, Gambia, Niger |
|
|
|
Institute for Global Orthopedics and Traumatology (IGOT) |
Richard Coughlin, MD |
Ethiopia, Kenya, Malawi, Mozambique, Rwanda, Seychelles, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Egypt, Morocco, Botswana, Namibia, South Africa, Ivory Coast, Ghana, Liberia, Mali, Niger, Nigeria, Sierra Leone, Kazakhstan, Tajikistan, Uzbekistan, China, Afghanistan, Bangladesh, India, Nepal, Viet Nam, Thailand, Philippines, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Brazil |
|
|
|
Eliminating Trachoma with Repeat Mass Drug Treatment |
Thomas Lietman, MD |
Ethiopia, Niger |
|
|
|
International AIDS Education and Training Center |
E. Michael Reyes, MD, MPH |
Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Gabon, Egypt, Morocco, Sudan, Tunisia, Botswana, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Ivory Coast, Gambia, Ghana, Guinea-Bissau, Mali, Niger, Nigeria, Senegal, Togo, Kyrgyzstan, China, Bangladesh, India, Iran, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Georgia, Iraq, Lebanon, Yemen, Czech Republic, Estonia, Greece, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Venezuela, Antigua and Barbuda, Bahamas, Barbados, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Puerto Rico, Trinidad and Tobago, Australia |
|
|